Authors:
Reesink-Peters, N
Ossewaarde, JM
Van der Zee, AGJ
Quint, WGV
Burger, MPM
Adriaanse, AH
Citation: N. Reesink-peters et al., No association of anti-Chlamydia trachomatis antibodies and severity of cervical neoplasia, SEX TRANS I, 77(2), 2001, pp. 101-102
Authors:
Tjiong, MY
Out, TA
Ter Schegget, J
Burger, MPM
Van der Vange, N
Citation: My. Tjiong et al., Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: A review, INT J GYN C, 11(1), 2001, pp. 9-17
Citation: Mpm. Burger, Management of stage 1 endometrial carcinoma - Postoperative radiotherapy is not justified in women with medium risk disease, BR MED J, 322(7286), 2001, pp. 568-569
Authors:
Reesink-Peters, N
Burger, MPM
Kleter, B
Quint, WGV
Bossuyt, PM
Adriaanse, AH
Citation: N. Reesink-peters et al., Using a new HPV detection system in epidemiological research: change of views on cervical dyskaryosis?, EUR J OB GY, 98(2), 2001, pp. 199-204
Authors:
Tjiong, MY
Ter Schegget, J
Tjong-A-Hung, SP
Out, TA
van der Vange, N
Burger, MPM
Struyk, L
Citation: My. Tjiong et al., IgG antibodies against human papillomavirus type 16 E7 proteins in cervicovaginal washing fluid from patients with cervical neoplasia, INT J GYN C, 10(4), 2000, pp. 296-304
Authors:
Baay, MFD
Duk, JM
Burger, MPM
de Bruijn, HWA
Stolz, E
Herbrink, P
Citation: Mfd. Baay et al., Humoral immune response against proteins E6 and E7 in cervical carcinoma patients positive for human papilloma virus type 16 during treatment and follow-up, EUR J CL M, 18(2), 1999, pp. 126-132
Authors:
Tjiong, MY
van der Vange, N
ten Kate, FJW
Tjong-A-Hung, SP
ter Schegget, J
Burger, MPM
Out, TA
Citation: My. Tjiong et al., Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer, GYNECOL ONC, 73(2), 1999, pp. 285-291
Authors:
Emanuels, AG
Koudstaal, J
Burger, MPM
Hollema, H
Citation: Ag. Emanuels et al., In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases, BR J CANC, 80(1-2), 1999, pp. 38-43